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Inﬂ  uenza A pandemic (H1N1) 2009 virus continues to 
rapidly spread worldwide. In 2009, pandemic (H1N1) 2009 
infection in a domestic cat from Iowa was diagnosed by a 
novel PCR assay that distinguishes between Eurasian and 
North American pandemic (H1N1) 2009 virus matrix genes. 
Human-to-cat transmission is presumed.
Inﬂ  uenza viruses are typically host speciﬁ  c; aquatic 
birds are considered the primary reservoir. However, in-
terspecies transmission does occur (1–9) and occasionally 
leads to novel host-adapted strains. Interspecies transmis-
sion of inﬂ  uenza virus has been a public health concern 
because of the possibility that, through reassortment, a 
novel strain with zoonotic potential could emerge. The re-
cent infection of dogs with equine inﬂ  uenza virus (H3N8) 
(2) and of swine with human inﬂ  uenza virus (H1N2) (4) 
are particularly intriguing because the former resulted in 
inﬂ  uenza becoming endemic in dogs and the latter resulted 
in a documented reassortment event between human and 
swine inﬂ  uenza viruses. Such concern has escalated with 
the recent emergence of the novel quadruple-reassorted in-
ﬂ  uenza virus (H1N1) [pandemic (H1N1) 2009] in humans 
(10). Although infection and transmission of the virus have 
occurred primarily among humans, occasional transmission 
from infected persons to susceptible animals (e.g., swine, 
turkeys, ferrets) has been documented (11). The likeli-
hood of pandemic (H1N1) 2009 infection of domestic pets 
has been considered less likely (www.cdc.gov/h1n1ﬂ  u/
qa.htm, www.avma.org/public_health/inﬂ  uenza/new_vi-
rus/default.asp, www.usda.gov/wps/portal/?navid=USDA_
H1N1); however, we report a conﬁ  rmed case of pandemic 
(H1N1) 2009 virus infection in a domestic cat that had been 
in contact with persons who had recently experienced inﬂ  u-
enza-like illness.
The Case
A 13-year-old, castrated male, domestic cat that lived 
indoors in a single-cat household was brought to the Iowa 
State University Lloyd Veterinary Medical Center be-
cause of depression, inappetance, and respiratory signs of 
4 days’ duration. The cat was gregarious and interacted 
closely with family members in the household. The fam-
ily members noted that the cat was reluctant to lie in lat-
eral recumbency and instead rested in sternal recumbency 
with neck extended, which was indicative of dyspnea. The 
cat’s vaccination status was up to date. Before the onset of 
clinical signs in the cat, 2 of the 3 family members had ex-
perienced an undiagnosed inﬂ  uenza-like illness—an upper 
respiratory tract infection characterized by fever, coughing, 
and myalgia—that lasted 3 days. Onset of the cat’s clinical 
signs was noted 6 and 4 days after onset of illness for the 
ﬁ  rst and second family members, respectively.
At the time of examination, the cat had bilateral ad-
ventitial lung sounds (wheezes), was afebrile, and was 
clinically dehydrated. Radiographs of the thorax showed 
a bilateral caudodorsal alveolar pattern (Figure). Cytologic 
and microbiologic examination of bronchoalveolar lavage 
(BAL) ﬂ  uid showed foamy macrophages (65%), nonde-
generate neutrophils (25%), and small lymphocytes (10%). 
Clinicopathologic ﬁ  ndings suggested a moderate, predomi-
nantly macrophagic, mixed inﬂ  ammatory process. Stan-
dard microbial culture of BAL aliquots yielded no substan-
tial growth of aerobic or anaerobic bacteria. Radiographic 
and cytologic ﬁ  ndings were inconsistent with bacterial or 
parasitic pneumonia and not supportive of allergic airway 
disease. A viral cause was considered most likely; how-
ever, the cat was given amoxicillin with clavulanate (125 
mg orally 2×/day) to reduce the possibility of secondary 
bacterial pneumonia. Notable ﬁ  ndings from laboratory test-
ing (complete blood count, serum biochemistry, urinalysis, 
and total thyroxine measurement) were moderate leuko-
penia characterized by a moderate lymphopenia, modest 
hemoconcentration, and a slightly elevated thyroxine level. 
Lymphopenia was consistent with acute viral infection.
PCR testing (Feline URD Panel; Idexx Laboratories, 
Westbrook, ME, USA) of a BAL sample showed negative 
results for Chlamydophila felis, feline calicivirus, feline 
herpesvirus-1, Bordetella bronchiseptica, and Mycoplasma 
felis. Results of feline immunodeﬁ  ciency virus (antibody) 
and feline leukopenia virus (antigen) testing (Idexx SNAP 
FIV/FeLV Combo Test; Idexx Laboratories) were also 
negative, ruling out the potential that viral-induced immu-
nosuppression was a concurrent factor. For the following 
reasons we included pandemic (H1N1) 2009 on our list of 
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differential diagnoses: recent history of respiratory disease 
in household family members, known widespread com-
munity prevalence of pandemic (H1N1) 2009 inﬂ  uenza 
in humans, paucity of common viral infections causing 
infectious caudodorsal alveolar pneumonia in adult cats, 
and documented susceptibility of felids to avian inﬂ  uenza 
(H5N1) (12,13). We therefore submitted a BAL sample to 
the Iowa State University Veterinary Diagnostic Labora-
tory for molecular screening and typing for inﬂ  uenza A and 
the pandemic (H1N1) 2009 virus.
RNA was obtained from the BAL ﬂ  uid by using the 
MagMAX Viral RNA Isolation Kit (Applied Biosystems, 
Austin, TX, USA) and a semiautomated magnetic par-
ticle processor (Kingﬁ  sher 96; Thermo Electron Corp., 
Woodstock, GA, USA) according to manufacturer’s rec-
ommendations. Molecular testing used a real-time reverse 
transcription–PCR (rRT-PCR) inﬂ  uenza A screening as-
say speciﬁ  c for the nucleoprotein gene. Preliminary dif-
ferentiation of pandemic (H1N1) 2009 virus from other 
H1 or H3 types of inﬂ  uenza A was performed by using an 
in-house rRT-PCR assay that distinguishes between pan-
demic (H1N1) 2009 [Eurasian matrix (10)] and endemic 
(to North America) swine H1N1 inﬂ  uenza viruses (North 
American matrix). Sequences of primers and probes are 
summarized in Table 1. PCRs were conducted by using 
the AgPath-ID Multiplex One-Step RT-PCR Kit (Am-
bion/Applied Biosystems) according to manufacturer’s 
recommendations; 10 units of Multiscribe Reverse Tran-
scriptase (Applied Biosystems) were added per reaction. 
Thermocycling was performed by using the Applied Bio-
systems 7500 Fast Real-Time PCR System according to 
manufacturer’s recommendations.
PCR testing showed the BAL sample to be positive for 
inﬂ  uenza A virus (nucleoprotein gene), and the virus was 
determined to contain the matrix (M) gene of the pandemic 
(H1N1) 2009 virus strain. A BAL sample was submitted to 
the US Department of Agriculture National Veterinary Ser-
vices Laboratories (Ames, IA, USA) for conﬁ  rmatory test-
ing. rRT-PCR conﬁ  rmed that the BAL sample was positive 
for the M gene of inﬂ  uenza A virus and the neuraminidase 
(N) gene of pandemic (H1N1) 2009 virus. Sequences of 
primers and probes are summarized in Table 2. A cytolytic 
virus was isolated by using MDCK cells (8) and was des-
ignated as A/feline/IA/NVSL026991/2009. PCR testing 
of the isolate for inﬂ  uenza A virus (M gene) and N1 gene 
of pandemic (H1N1) 2009 showed positive results. Se-
quence analyses for hemagglutinin (HA), N, and M genes 
conﬁ  rmed that the virus was pandemic (H1N1) 2009 virus 
(GenBank accession nos. GU332630 (for HA), GU332632 
(for NA), and GU332631 (for M). Nucleotide homologies 
with the ﬁ  rst US human pandemic (H1N1) 2009 isolate (A/
CA/04/2009) were 99.4%, 99.4%, and 99.8% for the HA, 
NA, and M genes, respectively.
The cat was discharged from the medical center after 
diagnostic testing and correction of dehydration. A veteri-
narian (B.A.S.) visited the home to monitor the cat’s clini-
cal status and administer subcutaneous ﬂ  uids (120–160 mL) 
until the cat’s appetite improved; adventitial lung sounds 
resolved within 3 days. Reassessment 1 week later showed 
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Figure. Radiographs of the thorax of a cat with conﬁ  rmed inﬂ  uenza 
A pandemic (H1N1) 2009 virus infection. A) Right lateral view; B) 
dorsoventral view. Asymmetric soft tissue opacities are evident in the 
right and left caudal lung lobes. An alveolar pattern, composed of air 
bronchograms with border-effaced (indistinct) adjacent pulmonary 
vessels, is most pronounced in the left caudal lobe. A small gas 
lucency in the pleural space appears in the right caudal and dorsal 
thoracic cavity. An endotracheal tube is visible at the thoracic inlet 
on the lateral view in this moderately obese cat. L, left.marked improvement of clinical signs but only modest im-
provement of the lymphopenia and radiographic ﬁ  ndings.
Conclusions
Because the cat was from a single-animal house-
hold and remained indoors, he was presumably infected 
through contact with the family members. Attempts to ret-
rospectively conﬁ  rm pandemic (H1N1) 2009 infection in 
the family members have been unsuccessful, but addition-
al testing of archived biologic samples is being conduct-
ed. Although more surveillance and studies are needed 
to determine susceptibility of companion animals to the 
pandemic (H1N1) 2009 virus, possible reverse zoonotic 
transmission (humans to animals) remains a concern. In-
deed, cases in a domestic dog and other felids have been 
conﬁ  rmed  (11) (www.cdc.gov/h1n1ﬂ  u/qa.htm,  www.
avma.org/public_health/inﬂ  uenza/new_virus/default.asp, 
www.usda.gov/wps/portal/?navid=USDA_H1N1). Impli-
cations of pandemic (H1N1) 2009 virus infection in com-
panion animals are 1) apparent human-to-animal trans-
mission; 2) broader host range for the virus; 3) potential 
endemic establishment of inﬂ   uenza in companion ani-
mals; 4) possible transmission of inﬂ  uenza from compan-
ion animals to other species, including humans; and 5) the 
need to reevaluate companion animals as potential reser-
voirs or intermediate hosts for reassortment of inﬂ  uenza 
virus. This case emphasizes the need for close monitor-
ing for interspecies transmission of inﬂ  uenza virus and 
reinforces the need for collaboration among many disci-
plines, a cornerstone of the One Health Initiative (www.
onehealthinitiative.com).
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Table 1. Oligonucleotide sequences for primers and probes and dye labels used in novel molecular testing for pandemic (H1N1) 2009 
virus, Iowa State University Veterinary Diagnostic Laboratory, Ames, Iowa, USA, 2009* 
Name  Sequence (5ƍ ĺ 3ƍ)  Description 
Influenza A NP screening assay     
  SIVRTF CGGACGAAAAGGCAACGA NP forward primer
  SIVRTR CTGCATTGTCTCCGAAGAAATAAG NP reverse primer
  SIVRTP CCGATCGTGCCYTC NP probe, MGB FAM
Pandemic influenza M differentiation assay     
  M_F TCAGGCCCCCTCAAAGC M forward primer
  M_R1  CATTCCATGAGAGCCTCAAGATC  M reverse primer 1
  M_R1a  CACTCCATGAGAGCCTCAAGATC  M reverse primer 2
  M_R1b  CATTCCATGAGTGCCTCAAGATC  M reverse primer 3
  M_EUPr  CAGAGACTGGAAAGTGT  EU M MGB, VIC
  M_NAPr CAGAGACTYGAAGAYGT NA M MGB, FAM
*Primers and MGB probes were obtained from Integrated DNA Technologies (Coralville, IA, USA) and Applied Biosystems Inc. (Foster City, CA, USA), 
respectively. SIV, swine influenza virus; NP, nucleoprotein; M, matrix. 
Table 2. Oligonucleotide sequences for primers and probes and dye labels used in confirmatory molecular testing for pandemic 
(H1N1) 2009 virus, National Veterinary Services Laboratories, Ames, Iowa, USA, 2009* 
Name  Sequence (5ƍ ĺ 3ƍ)  Description 
Influenza A M screening assay     
  M+25  AGATGAGTCTTCTAACCGAGGTCG  AI M forward primer
  M-124  TGCAAAAACATCTTCAAGTCTCTG  AI M reverse primer
  M-124siv  TGCAAAGACACTTTCCAGTCTCTG  H1N1 M reverse primer
  M+64  TCAGGCCCCCTCAAAGCCGA  M probe, BHQ, FAM
Pandemic influenza N1 differentiation assay     
  N1 220F  CAACACCAACTTTGCTGC  N1 forward primer 
  N1 330R  GGAACCGATTCTTACACTGTTGTC  N1 reverse primer 
  N1 232  CAGTCAGTGGTTTCCGTGAAATTAGC  N1 BHQ, FAM 
*Primers and probes were obtained from Integrated DNA Technologies (Coralville, IA, USA) and Biosearch Technologies, Inc. (Novato, CA, USA), 
respectively. M, matrix; AI, avian influenza; N, neuraminidase. Pandemic (H1N1) 2009 Virus in Domestic Cat
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